Christine Ocampo
Comptroller/Controller/Auditor presso UROVANT SCIENCES LTD.
Posizioni attive di Christine Ocampo
Società | Posizione | Inizio | Fine |
---|---|---|---|
UROVANT SCIENCES LTD. | Comptroller/Controller/Auditor | - | - |
Direttore Finanziario/CFO | 01/05/2018 | 28/10/2019 | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Comptroller/Controller/Auditor | 01/10/2017 | - |
Storia della carriera di Christine Ocampo
Precedenti posizioni note di Christine Ocampo
Società | Posizione | Inizio | Fine |
---|---|---|---|
ELEDON PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/05/2017 | 10/07/2017 |
Responsabile della Conformità | 01/05/2017 | 10/07/2017 | |
Direttore Finanziario/CFO | 01/05/2017 | 10/07/2017 | |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Responsabile della Conformità | 22/09/2015 | 01/05/2017 |
Direttore Finanziario/CFO | 22/09/2015 | 01/05/2017 | |
AVANIR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 17/03/2007 | 01/09/2015 |
Responsabile della Conformità | 17/03/2007 | 01/09/2015 | |
Direttore Finanziario/CFO | 17/03/2007 | 01/09/2015 | |
Segretario Aziendale | 17/03/2007 | 01/09/2015 | |
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Comptroller/Controller/Auditor | 01/01/2001 | 05/04/2006 |
Direttore Finanziario/CFO | 01/01/2001 | 05/04/2006 | |
Segretario Aziendale | 01/01/2001 | 05/04/2006 | |
Treasurer | 01/01/2001 | 05/04/2006 | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/01/1994 | 01/01/1996 |
Formazione di Christine Ocampo
Seattle University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Regno Unito | 2 |
Posizioni
Comptroller/Controller/Auditor | 6 |
Director of Finance/CFO | 5 |
Compliance Officer | 3 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ELEDON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 6 |
---|---|
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Borsa valori
- Insiders
- Christine Ocampo
- Esperienza